Beneath the surface: a case report of metastatic iridociliary ring melanoma treated with pembrolizumab.

Parra-Bernal, Cinthya; Aguilera-Partida, Jorge A; Dalvin, Lauren A; Rodríguez-Reyes, Abelardo A; Ancona-Lezama, David

Parra-Bernal, Cinthya; Aguilera-Partida, Jorge A; Dalvin, Lauren A; Rodríguez-Reyes, Abelardo A; Ancona-Lezama, David.

Afiliación

Parra-Bernal C; Ocular Oncology Service, Institute of Ophthalmology and Visual Sciences, Tecnologico de Monterrey, Monterrey, Mexico.
Aguilera-Partida JA; Uveitis and Ocular Inflammation Service, Clínica Oftalmológica Santa Lucía, Guadalajara, Jalisco, Mexico.
Dalvin LA; Department of Ophthalmology, Mayo Clinic, Rochester, Minnesota, United States.
Rodríguez-Reyes AA; Ophthalmic Pathology Service, Asociación Para Evitar La Ceguera en México, Hospital Dr. Luis Sanchez Bulnes, Mexico City, Mexico.
Ancona-Lezama D; Ocular Oncology Service, Institute of Ophthalmology and Visual Sciences, Tecnologico de Monterrey, Monterrey, Mexico.

Arq Bras Oftalmol ; 2022 Mar 21.

Article en En | MEDLINE | ID: mdl-35319657

RESUMEN

Iridociliary ring melanoma is an uncommon type of uveal melanoma. Clinical manifestation varies from asymptomatic cases to masquerade syndromes mimicking refractory glaucoma. Treatment options include radiotherapy and enucleation. Management of metastatic uveal melanoma remains discouraging. Novel therapies using immune checkpoint inhibitors are currently under study. We present a case of a 54-year-old Hispanic woman with progressive vision loss due to metastatic ring melanoma with anterior chamber seeding treated with pembrolizumab.

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Arq Bras Oftalmol Año: 2022 Tipo del documento: Article País de afiliación: México Pais de publicación: Brasil

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google